Evidence map›Paper›PMID 29719586›Full record

ArticleOncotarget2018

Cold atmospheric plasma as a potential tool for multiple myeloma treatment.

Dehui Xu, Yujing Xu, Qingjie Cui, Dingxin Liu, Zhijie Liu, Xiaohua Wang, Yanjie Yang, Miaojuan Feng, Rong Liang, Hailan Chen and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Dehui Xu *State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Yujing Xu *State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Qingjie CuiThe School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Dingxin LiuState Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Zhijie LiuState Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Xiaohua WangState Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Yanjie YangDepartment of Cardiovascular Medicine, First Affiliated Hospital of the Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, P.R. China.
Miaojuan FengDepartment of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China.
Rong LiangDepartment of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China.
Hailan ChenFrank Reidy Center for Bioelectrics, Old Dominion University, Norfolk, VA, 23508, USA.
Kai YeSchool of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Michael G KongState Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P.R. China.
Xi'an Jiaotong University · CNOld Dominion University · USXijing Hospital · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple myeloma (MM) is a fatal and incurable hematological malignancy thus new therapy need to be developed. Cold atmospheric plasma, a new technology that could generate various active species, could efficiently induce various tumor cells apoptosis. More details about the interaction of plasma and tumor cells need to be addressed before the application of gas plasma in clinical cancer treatment. In this study, we demonstrate that He+O

Indexed as

CD95cold atmospheric plasmamultiple myelomareactive oxygen speciesselective inactivation

Identifiers

PMID29719586
PMCPMC5915053
OpenAlexW2795652520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.